- Home
- MSIF vs TLRY Comparison
MSIF vs TLRY Comparison
Compare MSIF & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MSIF
- TLRY
- Stock Information
- Founded
- MSIF 2011
- TLRY N/A
- Country
- MSIF United States
- TLRY Canada
- Employees
- MSIF N/A
- TLRY N/A
- Industry
- MSIF
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- MSIF
- TLRY Health Care
- Exchange
- MSIF NYSE
- TLRY Nasdaq
- Market Cap
- MSIF 795.9M
- TLRY 708.1M
- IPO Year
- MSIF N/A
- TLRY 2018
- Fundamental
- Price
- MSIF $14.84
- TLRY $0.57
- Analyst Decision
- MSIF Buy
- TLRY Hold
- Analyst Count
- MSIF 5
- TLRY 3
- Target Price
- MSIF $18.50
- TLRY $1.38
- AVG Volume (30 Days)
- MSIF 80.8K
- TLRY 48.1M
- Earning Date
- MSIF 05-12-2025
- TLRY 07-28-2025
- Dividend Yield
- MSIF 9.76%
- TLRY N/A
- EPS Growth
- MSIF N/A
- TLRY N/A
- EPS
- MSIF 1.50
- TLRY N/A
- Revenue
- MSIF $134,105,000.00
- TLRY $821,309,000.00
- Revenue This Year
- MSIF $9.98
- TLRY $8.95
- Revenue Next Year
- MSIF $10.94
- TLRY $4.76
- P/E Ratio
- MSIF $9.93
- TLRY N/A
- Revenue Growth
- MSIF N/A
- TLRY 4.10
- 52 Week Low
- MSIF $14.01
- TLRY $0.35
- 52 Week High
- MSIF $18.10
- TLRY $2.11
- Technical
- Relative Strength Index (RSI)
- MSIF N/A
- TLRY 47.96
- Support Level
- MSIF N/A
- TLRY $0.55
- Resistance Level
- MSIF N/A
- TLRY $0.63
- Average True Range (ATR)
- MSIF 0.00
- TLRY 0.06
- MACD
- MSIF 0.00
- TLRY -0.02
- Stochastic Oscillator
- MSIF 0.00
- TLRY 6.68
About MSIF MSC INCOME FUND INC
MSC Income Fund Inc is a non-diversified closed-end management investment company. The investment objective is to generate current income through debt and equity investments and the secondary objective is to generate long-term capital appreciation through such investments. The company invests in senior secured term loans, second lien loans, and mezzanine debt and selected equity investments issued by lower middle-market and middle-market companies.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.